Zentylor tideglusib: Completed Phase II enrollment

Noscira completed enrollment of 146 patients in the double-blind, placebo-controlled, international Phase II TAUROS trial to evaluate once-daily 600 and 800 mg oral Zentylor for 1 year. Tideglusib has...